Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Positron emission tomography. Cost-benefit considerations]

T Kuwert1, P Matheja, B Vollet

  • 1Klinik und Poliklinik für Nuklearmedizin, Westfälische-Wilhelms-Universität Münster.

Der Radiologe
|April 1, 1996
PubMed
Summary

Positron emission tomography (PET) offers powerful non-invasive biochemical analysis and surpasses conventional diagnostics. However, high costs limit its clinical use, and its cost-effectiveness compared to traditional methods remains unverified in Germany.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational imaging of the fibroblast activation protein (FAP) using the new ligand [<sup>68</sup>Ga]Ga-OncoFAP-DOTAGA.

European journal of nuclear medicine and molecular imaging·2021
Same author

From the inside: GVHD and glucose metabolism.

Blood·2021
Same author

Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.

Pediatric blood & cancer·2018
Same author

Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer.

Radiation oncology (London, England)·2018
Same author

[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein].

Der Urologe. Ausg. A·2018
Same author

External radiation exposure, excretion, and effective half-life in <sup>177</sup>Lu-PSMA-targeted therapies.

EJNMMI research·2018

Area of Science:

  • Biomedical imaging
  • Nuclear medicine
  • Diagnostic technology

Background:

  • Positron emission tomography (PET) is a leading non-invasive imaging modality for studying biochemical processes.
  • PET demonstrates superiority over conventional diagnostic methods in various clinical applications.
  • Significant costs associated with PET technology impede its widespread clinical adoption.

Purpose of the Study:

  • To evaluate the cost-effectiveness of Positron Emission Tomography (PET) in clinical practice.
  • To compare the economic viability of PET versus conventional diagnostic work-up.
  • To verify the hypothesis of PET's cost-effectiveness in the German healthcare system.

Main Methods:

  • Review of existing American studies on PET cost-effectiveness.

Related Experiment Videos

  • Analysis of clinical indications where PET may offer advantages.
  • Comparative assessment of diagnostic work-up costs.

    • Main Results:

    • American studies suggest PET can be more cost-effective than conventional diagnostics for specific indications.
    • The cost-effectiveness of PET in Germany has not yet been substantiated.
    • High implementation costs remain a barrier to PET's clinical integration.

    Conclusions:

    • PET imaging holds significant potential for clinical diagnostics and research.
    • Further investigation is required to confirm the cost-effectiveness of PET in Germany.
    • Addressing cost barriers is crucial for expanding PET's clinical utility.